NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Source:http://linkedlifedata.com/resource/pubmed/id/16112301

Download in:

View as

General Info

PMID
16112301